Abstract:INTRODUCTION:Hepatocellular carcinoma is currently the second leading cause of cancer-related deaths worldwide with an increasing incidence.OBJECTIVE:The objective of this study is to investigate the effect of vascular endothelial growth factor small interfering RNA (VEGF-siRNA) on rabbit VX2 carcinoma cell viability in vitro and the effect of transarterial embolization (TAE)-mediated VEGF-siRNA delivery on the growth of rabbit VX2 liver-transplanted model in vivo.METHODS:Quantitative reverse transcription polymerase chain reaction, enzyme-linked immunosorbent assay, and Western blot technologies were used to detect the expression level of VEGF. TAE and computed tomography scan were used to deliver the VEGF-siRNA and detect the tumor volume in vivo, respectively. Microvessel density was detected by immunohistochemistry with CD34 antibody. A biochemical autoanalyzer was used to evaluate the hepatic and renal toxicity.RESULTS:The designed VEGF-siRNAs could effectively decrease the expression levels of VEGF mRNA and protein in vitro and in vivo. In vitro, the viability of rabbit VX2 carcinoma cells was reduced by 38.5%±7.3% (VEGF-siRNA no 1) and 30.0%±5.8% (VEGF-siRNA no 3) at 48 hours after transfection. Moreover, in rabbit VX2 liver-transplanted model, the growth ratios of tumors at 28 days after TAE-mediated siRNA delivery were 155.18%±19.42% in the control group, 79.67%±19.63% in the low-dose group, and 36.09%±15.73% in the high-dose group, with significant differences among these three groups. Microvessel density dropped to 34.22±4.01 and 22.63±4.07 in the low-dose group and high-dose group, respectively, compared with the control group (57.88±5.67), with significant differences among these three groups. Furthermore, inoculation of VX2 tumor into the liver itself at later stage induced significant increase in alanine aminotransferase and aspartate aminotransferase, indicating an obvious damage of liver functions, while treatment of VX2 tumor via TAE-mediated VEGF-siRNA had no toxicity to the livers and kidneys of rabbits, and VEGF-siRNA had the ability to protect liver damage induced by tumor growth.CONCLUSION:This is the first study to demonstrate that targeting VEGF via TAE-mediated siRNA delivery may become a powerful new option for effective treatment of hepatocellular carcinoma in the clinic.

[Vector-Mediated HER-2 RNA Interference Against HER-2-positive Breast Cancer].

Inhibition of cell proliferation of lung cancer by vector based-small interfering RNA targeting HER2 gene

[Downregulation of HER2 by Adenovirus-Mediated RNA Interference and Its Inhibitory Effect on Growth of SKBR3 Breast Cancer Cell].

Silencing of HER2 Receptor and Growth Inhibition of SKBR3 Breast Cancer Cells by Lentiviral- Mediated RNAi

RNA Interference to Silence Human HER2/neu Gene

Expression of Sirna Vector Against HER2 in the Human Breast Carcinoma SKBr-3 Cells

Inhibition of tumor growth of non-small cell lung cancer by small interfering RNA targeting to HER2/neu gene

Inhibition of Cell Proliferation and Colony Formation in Overexpression HER2/neu Adenocarcinoma Cell of Lung by Vector Based-Small Interfering RNA

Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth in vitro and in vivo.

Vector construction and silencing effect of HER4 gene targeted small interfering RNA

RNAi Silencing of HER2 Gene Induces Apoptosis and Antiproliferative Effect of SK-BR-3 Cell Line

Effects of RNAi on HER2/neu Gene and Proliferation of SK-OV-3 Ovarian Cancer Cells in Vitro

Inhibition Of Breast Cancer Cell Growth And Invasiveness By Dual Silencing Of Her-2 And Vegf

HER2-targeted RNA Interference Inhibits Growth and Invasion of Human Gastric Carcinoma Cell SGC-7901

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

Inhibitory Effects of Her-2/neu Gene in SKOV3.ip1 Cell by RNA Interference

Small Interfering RNAs Directed Against VEGF Gene Inhibit Proliferation of Breast Cancer Cells in Vitro and in Vivo

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Efficiently Inhibits Growth of VX2 Cells and VX2 Tumor Model of Hepatocellular Carcinoma in Rabbit by Transarterial Embolization-Mediated Sirna Delivery.

Effect of lentivirus mediated HER2-shRNA on chemosensitivity of human ovarian cancer SKOV3 cells

[Effect of Reduced Expression of Her2 by RNA Interference on the Biological Characters of Ovarian Carcinoma Cells].

RNA Interference Silence HER2 Expression in Salivary Gland Mucoepidermoid Carcinoma Cell Line Mc3